SHY THERAPEUTICS, LLC
Biotech · Private
Novel small-molecule antifungal compounds targeting drug-resistant fungal pathogens
- Grants
- $301K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 14 granted · 26 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Development of a Novel Class of Antifungal Therapy | $300,616 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1519 | DEGROME THERAPEUTICS, INC. | — | — |
| 1520 | Bell Biosystems, Inc. | — | $2.4M |
| 1521 | MOSAIC ENGINEERING LLC | — | — |
| 1522 | SHY THERAPEUTICS, LLC | — | — |
| 1523 | Varda Space | — | — |
| 1524 | Phenzyme, Inc. | — | — |
| 1525 | Jabez Biosciences, Inc. | — | $3.9M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Diseasegranted
- Compounds That Interact With Ras Superfamily Proteins For Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic Diseasegranted
- Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Diseaseapplication
- Compounds That Interact With Ras Superfamily Proteins For Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic Diseaseapplication
- Compounds that Interact with the RAS Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Diseasegranted
- Compounds for the Treatment of Cancer and Inflammatory Diseaseapplication
- Compounds for the Treatment of Cancer and Inflammatory Diseasegranted
- Methods for the Treatment of Fibrotic Diseaseapplication
- Methods for the Treatment of Fibrotic Diseaseapplication
- Substituted Thienopyrimidines That Interact With The Ras Superfamily For The Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic Diseaseapplication
- Compounds For The Treatment Of Cancer And Inflammatory Diseasegranted
- Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic Diseasegranted
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.